Office of the Director, National Institutes of Health; Notice of Meeting, 34028-34029 [2021-13646]
Download as PDF
34028
Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices
Dated: June 11, 2021.
Paul Reed,
Rear Admiral, U.S. Public Health Service,
Deputy Assistant Secretary for Health,
Director, Office of Disease Prevention and
Health Promotion.
[FR Doc. 2021–13667 Filed 6–25–21; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, PAR–
20–181: Limited Competition: National
Primate Research Centers (P51), July 01,
2021, 10:00 a.m. to July 02, 2021, 06:00
p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
June 02, 2021, FR Doc 2021–11521, 86
FR 29590.
This meeting is being amended to
change the start date from July 01, 2021
to June 29, 2021 and the start time from
10:00 a.m. to 12:30 p.m. The meeting is
closed to the public.
Dated: June 22, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13690 Filed 6–25–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 20–
VerDate Sep<11>2014
17:39 Jun 25, 2021
Jkt 253001
243: Digital Healthcare Interventions to
Address the Secondary Health Effects Related
to Social, Behavioral and Economic Impact of
COVID–19.
Date: July 8, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paul Hewett-Marx, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (240) 672–8946, hewettmarxpn@
csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 22, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13689 Filed 6–25–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Center Support Grant (P30).
Date: August 19, 2021.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: David G. Ransom, Ph.D.,
Chief, Special Review Branch, Resources and
Frm 00062
Fmt 4703
Sfmt 4703
Dated: June 22, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13688 Filed 6–25–21; 8:45 am]
BILLING CODE 4140–01–P
National Cancer Institute; Notice of
Closed Meetings
PO 00000
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W104, Rockville, Maryland 20850,
240–276–6351, david.ransom@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Cancer
Centers Study Section (A).
Date: August 20, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W530, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W530, Rockville, Maryland 20892,
240–276–6442, ss537t@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH Videocast
https://videocast.nih.gov/ and the
CCRHB website https://
ccrhb.od.nih.gov/meetings.html.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: July 23, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: Presentations of Mental Health
Support, Ending Structural Racism, and The
Hepatitis C Story.
E:\FR\FM\28JNN1.SGM
28JNN1
Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices
Place: National Institutes of Health,
Building 31, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
[FR Doc. 2021–13646 Filed 6–25–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0105]
Application To Use Automated
Commercial Environment (ACE)
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 30-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
DATES: Comments are encouraged and
must be submitted (no later than July
28, 2021) to be assured of consideration.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
17:39 Jun 25, 2021
Jkt 253001
FOR FURTHER INFORMATION CONTACT:
Requests for additional PRA information
should be directed to Seth Renkema,
Chief, Economic Impact Analysis
Branch, U.S. Customs and Border
Protection, Office of Trade, Regulations
and Rulings, 90 K Street NE, 10th Floor,
Washington, DC 20229–1177,
Telephone number 202–325–0056 or via
email CBP_PRA@cbp.dhs.gov. Please
note that the contact information
provided here is solely for questions
regarding this notice. Individuals
seeking information about other CBP
programs should contact the CBP
National Customer Service Center at
877–227–5511, (TTY) 1–800–877–8339,
or CBP website at https://www.cbp.
gov/.
CBP
invites the general public and other
Federal agencies to comment on the
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.). This proposed information
collection was previously published in
the Federal Register (Volume 86 FR
14937) on March 19, 2021, allowing for
a 60-day comment period. This notice
allows for an additional 30 days for
public comments. This process is
conducted in accordance with 5 CFR
1320.8. Written comments and
suggestions from the public and affected
agencies should address one or more of
the following four points: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
suggestions to enhance the quality,
utility, and clarity of the information to
be collected; and (4) suggestions to
minimize the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses. The
comments that are submitted will be
summarized and included in the request
for approval. All comments will become
a matter of public record.
SUPPLEMENTARY INFORMATION:
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
SUMMARY:
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
34029
Overview of This Information
Collection
Title: Application to Use Automated
Commercial Environment (ACE).
OMB Number: 1651–0105.
Current Actions: Extension.
Type of Review: Extension (without
change).
Affected Public: Businesses.
Abstract: The Automated Commercial
Environment (ACE) is a trade data
processing system that is replacing the
Automated Commercial System (ACS),
the current import system for U.S.
Customs and Border Protection (CBP)
operations. ACE is authorized by
Executive Order 13659 which mandates
implementation of a Single Window
through which businesses will transmit
data required by participating agencies
for the importation or exportation of
cargo. See 79 FR 10655 (February 25,
2014). ACE supports government
agencies and the trade community with
border-related missions with respect to
moving goods across the border
efficiently and securely. Once ACE is
fully implemented, all related CBP trade
functions and the trade community will
be supported from a single common
user interface.
To establish an ACE Portal account,
participants submit information such as
their name, their employer
identification number (EIN) or social
security number (SSN), and if
applicable, a statement certifying their
capability to connect to the internet.
This information is submitted through
the ACE Secure Data Portal which is
accessible at: https://www.cbp.gov/trade/
automated.
Please Note: A CBP-assigned number
may be provided in lieu of your SSN. If
you have an EIN, that number will
automatically be used and no CBP
number will be assigned. A CBPassigned number is for CBP use only.
There is a standalone capability for
electronically filing protests in ACE.
This capability is available for
participants who have not established
ACE Portal Accounts for other trade
activities, but desire to file protests
electronically. A protest is a procedure
whereby a private party may
administratively challenge a CBP
decision regarding imported
merchandise and certain other CBP
decisions. Trade members can establish
a protest filer account in ACE through
a separate application and the
submission of specific data elements.
See 81 FR 57928 (August 24, 2016).
Type of Information Collection:
Application to ACE (Import)
Estimated Number of Respondents:
21,100.
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 86, Number 121 (Monday, June 28, 2021)]
[Notices]
[Pages 34028-34029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13646]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be held as a virtual meeting and open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting should notify the Contact Person listed below in advance of the
meeting. The meeting can be accessed from the NIH Videocast https://videocast.nih.gov/ and the CCRHB website https://ccrhb.od.nih.gov/meetings.html.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: July 23, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: Presentations of Mental Health Support, Ending
Structural Racism, and The Hepatitis C Story.
[[Page 34029]]
Place: National Institutes of Health, Building 31, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Patricia B. Hansberger,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2021-13646 Filed 6-25-21; 8:45 am]
BILLING CODE 4140-01-P